Swisse Continues To Grow In China While Sales Stabilize in Australia
Executive Summary
Australian-heritage supplements brand Swisse saw sales grow double-digits in China in the first half of 2021, while also returning to growth in Australia and New Zealand.
You may also be interested in...
Swisse Wellness Eyes Global Expansion After Conquering China's Supplements Market
Having cemented leading positions in China and Australia, Swisse Wellness' owners H&H Group are looking to grow the reach of the premium supplements brand across Europe and Asia-Pacific. The firm is targeting 25% growth for Swisse this year after double-digit growth in 2018.
Euro Q1 Consumer Health Earnings Preview: Reckitt, Sanofi, Haleon, Bayer
Major Europe-based consumer health players Reckitt, Sanofi, Haleon and Bayer feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q1 2024 results over the coming weeks.
Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories
Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.